WHO prequalifies maternal RSV vaccine to protect infants The Lancet Infectious DiseasesTimothy Jesudason
The vaccine product development pipeline is diverse with the most advanced clinical candidate currently in phase III efficacy testing in pregnant women. In addition, a long-acting RSV-neutralizing monoclonal antibody (mAb) to be administered at birth to prevent serious RSV-related respiratory disease ...
Get the influenza (flu) vaccine as soon as recommended each year, usually starting in September or October. Get the pneumonia and respiratory syncytial virus (RSV) vaccines, if recommended. Your healthcare provider can tell you if you also need other vaccines, and when to get them. Where...
(“…that Secretary Kennedy feels he knows enough to sign off on the Chikungunya vaccine votes but not the RSV and meningitis vaccine votes is alarming—not for the vaccines, but for the American people who would benefit from the now held-up vaccines. On what basis is Kennedy able to adjud...
While the age of first infection is expected to shift to older ages with the use of mAbs, evidence should be provided indicating an overall reduced risk of severe RSV disease compared to no intervention.If more than one dose of mAb is to be given, then the impact of anti-drug antibodies...
If you're young and healthy, the vaccine may not benefit you as much, but you still should consider getting it if you live with someone in one of these categories or want to reduce the risk of a COVID-19 infection. Overall, there is little to no harm in getting the vaccine for prot...
The Centers for Disease Control and Prevention has recommended the 2023–2024 COVID-19 (mRNA) vaccine for everyone six months or older. The COVID-19 vaccine is strongly recommended for people who face the highest risk of experiencing complications from t